Publikation

Practical "1-2-3-4-Day" Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study.

Wissenschaftlicher Artikel/Review - 02.02.2022

PubMed
DOI
Kontakt

Zitation
Kimura S, Toyoda K, Yoshimura S, Minematsu K, Yasaka M, Paciaroni M, Werring D, Yamagami H, Nagao T, Yoshimura S, Polymeris A, Zietz A, Engelter S, Kallmünzer B, Cappellari M, Chiba T, Yoshimoto T, Shiozawa M, Kitazono T, Koga M, SAMURAI, RELAXED, RAF, RAF-NOAC, CROMIS-2, NOACISP LONGTERM, Erlangen Registry and Verona Registry Investigators. Practical "1-2-3-4-Day" Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study. Stroke 2022; 53:1540-1549.
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
Stroke 2022; 53
Veröffentlichungsdatum
02.02.2022
eISSN (Online)
1524-4628
Seiten
1540-1549
Kurzbeschreibung/Zielsetzung

The "1-3-6-12-day rule" for starting direct oral anticoagulants (DOACs) in patients with nonvalvular atrial fibrillation after acute ischemic stroke or transient ischemic attack recommends timings that may be later than used in clinical practice. We investigated more practical optimal timing of DOAC initiation according to stroke severity.